^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Acute Myelogenous Leukemia |
| Drug: | cytarabine (DNA synthesis inhibitor, DNA-directed DNAP inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
10/14/2020
Excerpt:
Acute Myeloid Leukemia (Age ≥18 years): Therapy for Relapsed/Refractory Disease…LDAC (category 2B)...
